CDMRP PRMRP Discovery Award | W81XWH 21 PRMRP DA

Opportunity Information: Apply for W81XWH 21 PRMRP DA

The CDMRP PRMRP Discovery Award (Funding Opportunity Number W81XWH 21 PRMRP DA) is a Department of Defense research funding opportunity administered by the U.S. Army Medical Research Acquisition Activity (USAMRAA) under the Peer Reviewed Medical Research Program (PRMRP). It is designed to push medical research in bold, unconventional directions by supporting projects that are intentionally high-risk but have the potential for high reward. The central purpose is to generate genuinely new insights, paradigms, technologies, or practical applications that could reshape how a problem is understood or addressed, rather than simply extending what is already known.

The program is explicit that innovation is the single most important review criterion. In practice, that means reviewers are looking for ideas that break from standard approaches: projects that introduce a new conceptual framework, apply a novel method or tool in a way that changes what is possible, or reframe an established scientific or clinical problem from an unexpected perspective. Proposals that mainly represent incremental progress on previously published work are not considered a good fit for this mechanism, even if they are well executed. The goal is not to fund “the next logical step,” but the kind of leap that can open up entirely new lines of investigation.

Even though the award emphasizes risk-taking and creativity, the solicitation also makes clear that the proposed work must be scientifically grounded. Applicants are expected to present a well-formulated, testable hypothesis supported by a sound scientific rationale, along with a study design that credibly tests the hypothesis. In other words, the program wants unconventional ideas, but it also wants those ideas expressed as rigorous, hypothesis-driven science with clear logic, methods, and an approach that can produce interpretable results.

Another major theme is that Discovery Award projects should serve as a foundation for follow-on research. The funded studies are expected to “lay the groundwork” for future avenues of scientific investigation within the DoD’s medical research priorities for FY21. This positions the award as an early-stage catalyst: funding is aimed at producing proof-of-concept evidence, new enabling technologies, or compelling preliminary data that could support larger efforts later.

From an administrative standpoint, this is a discretionary federal opportunity in the science and technology / research and development category (CFDA 12.420). The funding instrument types listed are grant and cooperative agreement, meaning awards may vary in the level of government involvement depending on the project and terms. Eligibility is described as unrestricted (open to any type of entity), subject to any additional eligibility clarifications provided in the full announcement. The opportunity was created March 15, 2021, with an original closing date of May 13, 2021. The listing notes an expected 75 awards and shows an award ceiling of 0, which typically indicates that the specific maximum funding level is not stated in that summary field and must be confirmed in the full solicitation text.

Overall, this opportunity is best understood as DoD funding aimed at transformative, creative medical research that is bold in concept but disciplined in execution, with the explicit expectation that successful projects will open new directions and enable larger, future studies rather than simply polishing or slightly extending established work.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "CDMRP PRMRP Discovery Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Mar 15, 2021.
• Applicants must submit their applications by May 13, 2021. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 75 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 21 PRMRP DA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: